HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nondisjunction of human acrocentric chromosomes: studies of 432 trisomic fetuses and liveborns.

Abstract
The present report summarizes molecular studies on the parent and meiotic stage of origin of the additional chromosome in 432 fetuses or liveborns with an additional chromosome 13, 14, 15, 21, or 22. Our studies suggest that there is little variation in the origin of nondisjunction among the five acrocentric trisomies and that there is no association between the origin of nondisjunction and the likelihood of survival to term of the trisomic conceptus. The proportion of cases of paternal origin was similar among the five trisomies: 12% for trisomy 13, 17% for trisomy 14, 12% for trisomy 15, 9% for trisomy 21, and 11% for trisomy 22. The stage of nondisjunction was also similar among the five trisomies, with the majority of cases of maternal origin being due to nondisjunction at meiosis I, whereas for paternally derived cases, nondisjunction occurred primarily at meiosis II.
AuthorsM V Zaragoza, P A Jacobs, R S James, P Rogan, S Sherman, T Hassold
JournalHuman genetics (Hum Genet) Vol. 94 Issue 4 Pg. 411-7 (Oct 1994) ISSN: 0340-6717 [Print] Germany
PMID7927339 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Genetic Markers
Topics
  • Adult
  • Chromosomes, Human, Pair 13
  • Chromosomes, Human, Pair 14
  • Chromosomes, Human, Pair 15
  • Chromosomes, Human, Pair 21
  • Chromosomes, Human, Pair 22
  • Fetus
  • Genetic Markers
  • Humans
  • Infant, Newborn
  • Middle Aged
  • Nondisjunction, Genetic
  • Parents
  • Polymerase Chain Reaction
  • Polymorphism, Genetic
  • Trisomy (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: